DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

NCT00239330 ·Status: COMPLETED ·Phase: PHASE3

Effect of Crestor on Lipoprotein Metabolism in Humans

NCT00214617 ·Status: COMPLETED ·Phase: PHASE4

DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin

NCT02300363 ·Status: COMPLETED ·Phase: PHASE1

Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)

NCT00240266 ·Status: COMPLETED ·Phase: PHASE3

A Diabetes Study to Treat A Population Previously Not at Target

NCT00747149 ·Status: COMPLETED ·Phase: PHASE4

Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome

NCT05306990 ·Status: COMPLETED ·Phase: NA

DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia

NCT00241488 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease

NCT00235950 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

NCT00240305 ·Status: COMPLETED ·Phase: PHASE3

Crestor Versus Placebo in Subjects With Heart Failure

NCT00206310 ·Status: COMPLETED ·Phase: PHASE3

Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)

NCT00526552 ·Status: COMPLETED

ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants

NCT06293742 ·Status: COMPLETED ·Phase: PHASE1

The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus

NCT02418884 ·Status: UNKNOWN ·Phase: PHASE4

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

NCT00654602 ·Status: COMPLETED ·Phase: PHASE3

Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome

NCT00815659 ·Status: COMPLETED ·Phase: PHASE4

Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

NCT00296387 ·Status: COMPLETED ·Phase: PHASE3

LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

NCT00214630 ·Status: COMPLETED ·Phase: PHASE3

Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions

NCT01241903 ·Status: COMPLETED ·Phase: PHASE1

Potential Drug Interaction Between ALXN2040 and Rosuvastatin

NCT05708573 ·Status: COMPLETED ·Phase: PHASE1

To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia

NCT00726362 ·Status: COMPLETED

Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome

NCT00335699 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects

NCT01101568 ·Status: COMPLETED ·Phase: PHASE1

Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease

NCT00296400 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia

NCT00506961 ·Status: COMPLETED ·Phase: PHASE4

DESIFOR-EXPAND (MHIF)

NCT06804980 ·Status: RECRUITING ·Phase: PHASE4